Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1-2 trial of an unspecified antitumor agent in Japan (jRCT2080223532)
jRCT2080223532Phase 2Completed
- Start
- May 2017
01
Overview
Phase 2 trial in cancer. Started May 2017; status: completed.
02
Conditions
cancer
Beyond the preview
Go deeper on jRCT2080223532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223532.